David Morris Sells 187,855 Shares of Guardian Pharmacy Services (NYSE:GRDN) Stock

Key Points

• Insider sale: David Morris sold 187,855 shares on March 20 at an average price of $29.68 for proceeds of about $5.58M, cutting his stake by 42.47% to 254,472 shares (SEC filing).
• Quarterly beat: Guardian reported EPS of $0.37 versus $0.27 expected and revenue of $397.6M, up 17.4% year-over-year.
• Analyst sentiment: The consensus rating is "Buy" with an average target of $38.00, and several firms (Raymond James, Oppenheimer, Stephens, Zacks) have recently raised targets or upgraded the stock.

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider David Morris sold 187,855 shares of the business's stock in a transaction on Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $5,575,536.40. Following the transaction, the insider directly owned 254,472 shares in the company, valued at $7,552,728.96. This trade represents a 42.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Guardian Pharmacy Services Stock Up 0.9%

NYSE GRDN opened at $37.58 on Wednesday. The business's fifty day simple moving average is $32.49 and its 200-day simple moving average is $29.83. The firm has a market cap of $2.38 billion, a PE ratio of 48.81 and a beta of 0.86. Guardian Pharmacy Services, Inc. has a 52 week low of $19.17 and a 52 week high of $38.12.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.10. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The company had revenue of $397.62 million for the quarter, compared to analyst estimates of $390.04 million. The firm's revenue was up 17.4% compared to the same quarter last year. Research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analyst Upgrades and Downgrades

GRDN has been the topic of a number of research analyst reports. Stephens lifted their target price on Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an "overweight" rating in a research report on Wednesday, January 14th. Raymond James Financial reissued an "outperform" rating and set a $40.00 price objective on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Weiss Ratings restated a "hold (c+)" rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Oppenheimer upped their target price on shares of Guardian Pharmacy Services from $35.00 to $38.00 and gave the company an "outperform" rating in a research report on Thursday, March 12th. Finally, Zacks Research raised shares of Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $38.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. State of Alaska Department of Revenue acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at $30,000. Ameritas Investment Partners Inc. lifted its stake in Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company's stock worth $43,000 after acquiring an additional 345 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Guardian Pharmacy Services during the 2nd quarter worth about $43,000. Police & Firemen s Retirement System of New Jersey boosted its holdings in Guardian Pharmacy Services by 76.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company's stock valued at $52,000 after acquiring an additional 1,062 shares during the period. Finally, State of Wyoming purchased a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $58,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.